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ABSTRACT: The vaporization enthalpy of imidazo[1,2-a]pyrazine is evaluated by
correlation gas chromatography using two sets of standards and by transpiration.
Vaporization enthalpies were evaluated using heterocyclic standards with dipole moments
that vary from 0 to 3.0 D and using standards with dipole moments > 3.0 D. A value of
(70.7 ± 1.0) kJ·mol−1 measured by transpiration compares to (67.9 ± 1.4) kJ·mol−1
measured by correlation gas chromatography using standards characterized by dipole
moments > 3.0 D. The results suggest that imidazo[1,2-a]pyrazine is a member of this
series of compounds whose vaporization enthalpies exceed those less polar heterocycles
by a fairly constant amount, (6.9 ± 0.3) kJ·mol−1, in this case by (5.9 ± 3.0) kJ·mol−1
using the less polar heterocycles. The crystal structures of phthalazine, another member
of the polar series, and of imidazo[1,2-a]pyrazine were determined to examine whether
π−π stacking, present in the solid state of two other members of the polar series,
was a characteristic of this series. If present in the liquid, π−π stacking could oﬀer
a possible explanation for the vaporization enthalpy diﬀerences observed. The
sublimation enthalpy of imidazo[1,2-a]pyrazine was also evaluated.
1. INTRODUCTION
Structure plays a key role in enzyme inhibition although many
other factors inﬂuence eﬃcacy. These include lipophilicity,
hydrogen bonding, and polarity. The latter is frequently
inﬂuenced by electronic eﬀects mediated by substituents and
conjugation. In the course of evaluating the vaporization
enthalpies of a series of heterocycles by correlation gas
chromatography, we have observed that certain heterocycles
have unusually stronger intermolecular interactions with
themselves and presumably with other polar substances than
related substances with similar structures.1 Using dipole moment
as a criterion of polarity, enthalpies of transfer from the stationary
phase of the column to the gas phase, ΔtransHm(Tm), as measured
by gas chromatography were found to correlate linearly with
their respective vaporization enthalpies for a series of heterocycles
with dipole moments that varied from 0 to approximately 3.0 D,
whereas molecules with dipole moments > 3.0 D were found
to be outliers in these correlations. The enthalpies of transfer of
the outliers themselves, did correlate linearly with their respective
vaporization enthalpies when correlated in a similar manner.
Vaporization enthalpy diﬀerences between the two sets of sub-
stances diﬀered by (6.9 ± 0.3) kJ·mol−1.1
Materials previously examined with dipole moments < 3.0 D
included, pyrazine (1), pyrimidine (2), 2-N,N-dimethylaminopyr-
idine (3), 1,5-diazobicyclo[4.30]non-5-ene (4), and others.
Compound with dipole moments > 3.0 included 1-methylimida-
zole (7), pyridazine (8) and 4-N,N-dimethylaminopyridine (9),
and 1,5-diazabicyclo[4.3.0]non-5-ene (10), among others.1−3 The
structures of a number of these materials are provided in Figure 1.
As noted in the legend, the top row of closely related structures
consists of compounds whose enthalpy of transfer and cor-
responding vaporization enthalpy correlated linearly with each
other and with those of other similar substances characterized
with dipole moments < 3.0 D, whereas the bottom row consists
of compounds characterized with dipole moments > 3.0 D. The
enthalpies of transfer and corresponding vaporization enthalpies
of the latter materials correlated with others possessing similar
polarities.
We have observed that derivatives of many of the parent com-
pounds characterized by dipole moments > 3 D are frequently
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popular pharmacophores. 1-Hydrazinylphthalazine (14) used to
treat hypertension is on the World Health Organizations List of
Essential Medicines,4 Figure 2. 1,2,4-Triazolo[1,5-a]pyrimidine
(11) and imidazo[1,2-a]pyridine (10) derivatives are reported
to be physiologically active possessing a broad spectrum of
activity including anticancer and antiviral properties.5,6 Imidazo-
[1,2-a]pyridine-3-carboxamides, compound 15 and derivatives
for example, appear to be a new class of potent selective
antituberculosis agents.7,8 BKM-120 (16, Figure 2), currently
under evaluation in human clinical trials as a phosphoinositide-
3-kinase (PI3K) inhibitor, has a similar 4-N,N-dialkylaminopyridinyl
scaﬀold as found in 4-N,N-dimethylaminopyridine (9).9 The
enzyme, PI3K, which exists in several isoforms, plays an important
role in cancer cell growth, survival, angiogenesis and metath-
esis.9−12 Compounds 16 and 17 in Figure 2 illustrate exam-
ples of two classes of a series of novel imidazo[1,2-a]pyrazine
PI3K inhibitors reported recently.12 These and other observa-
tions raise the following question: Do the energetics associated
with an enhanced polarity of the parent scaﬀold play any role
in the eﬃcacy of enzyme inhibition if other important factors
such as stereochemistry, lipophilicity, and hydrogen bonding are
taken into account?
The structure of the materials with dipoles > 3 D share several
common physical properties. They are all polar, planar, and
exhibit extensive conjugation. Benzo[c]cinnoline (13, Figure 1)
for example, has been reported to form dimers in solution,
presumably as a result of the large dipole moment.13 The solid
state structure of benzo[c]cinnoline can be considered an
assembly of isolated coplanar pairs of molecules 3.473 Å apart.14
This solid state structure has been suggested as a model for
the dimer in solution. 1,2,4-Triazolo[1,5-a]pyrimidine, also very
polar, packs in columns, with the center of each coplanar
molecule slightly oﬀset from each other 3.253 Å apart.1
The solid state structure of phthalazine, the only other
crystalline member of this group to be identiﬁed is currently
unknown.
Imidazo[1,2-a]pyrazine, Figure 3, combines pyrazine (1), found
to correlate with compounds exhibiting dipole moments < 3.0 D,
the top row of Figure 1, with an N-substituted imidazole,
a member of the group of molecules with dipoles > 3 D. The
dipole moment of imidazo[1,2-a]pyrazine is current unknown.
This work examines the vaporization enthalpy of imidazo-
[1,2-a]pyrazine to determine to which set it is a member.
Several other thermodynamic properties of this material alone
with the solid state structure of both imidazo[1,2-a]pyrazine and
phthalazine are also reported to determine if π−π stacking in the
solid state is a characteristic of all polar substances that share the
common characteristics described above. Molecular association,
Figure 1. Top row: pyrazine (1), pyrimidine (2), 2-N,N-dimethylaminopyridine (3), 1,5-diazobicyclo[4.30]non-5-ene (4), 1,8-diazabicyclo[5.4.0]-
undec-7-ene (5) and quinazoline (6); a series of heterocycles whose enthalpies of transfer and vaporization enthalpies correlate with standards
characterized by dipole moments < 3.0 D. Bottom row: N-methylimidazole (7), pyridazine (8), 4-N,N-dimethylaminopyridine (9), imidazo[1,2-
a]pyridine (10), 1,2,4-triazolo[1,5-a]pyrimidine (11), phthalazine (12) and benzo[c]cinnoline (13); a series of heterocycles whose enthalpies of
transfer and vaporization enthalpies correlate with standards characterized by dipole moments > 3.0 D.
Figure 2. Structures of 1-hydrazinylphthalazine (14), an imidazo[1,2-
a]pyridine-3-carboxamide (15) and an example of two classes of PI3K
inhibitors (16, 17).
Figure 3. Structure of imidazo[1,2-a]pyrazine.
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if persistent in the liquid phase is a possible explanation for the
vaporization enthalpy diﬀerences observed.
2. EXPERIMENTAL SECTION
2.1. Materials. 2.1.1. Materials (St. Louis). The origin and
purity of the compounds as reported by the suppliers are
reported in Table 1. Commercial imidazo[1,2-a]pyrazine, 97 %
(St. Louis) was dissolved, ﬁltered, and recrystallized from ethyl
acetate−hexane before use and analyzed by gas chromatography.
A sample was also sublimed under reduced pressure and the
sublimed sample recrystallized from heptane. Analysis following
recrystallization or sublimation indicated a mass fraction > 0.99
as measured by gas chromatography using an FID detector.
The crystal structure of phthalazine was performed on the
commercial sample.
2.1.2. Materials (Rostock). The degree of purity of the
material purchased from Aldrich was determined using a GC on
an HP-5 capillary column, column length of 30 m, 0.32 mm ID,
and ﬁlm thickness of 0.25 μm. No impurities (greater than
0.02 mass percent) could be detected by GC in the imidazo-
[1,2-a]pyrazine sample used for the vapor pressure measure-
ments using the transpiration method.
2.2. Preconditioning of the imidazo[1, 2-a]pyrazine
sample (Rostock). The IR spectrum of commercial imidazo-
[1,2-a]pyrazine shows a broad OH band speciﬁc for hydrate
formation that is absent in the anhydrous form. In order to
remove water from the sample, a careful preconditioning of the
sample was performed inside of the saturator prior to the trans-
piration experiments. After ﬁlling of the U-shaped saturator
with the sample (as received of commercial origin), the carrier
gas with the ﬂow rate of 1 dm3·h−1 was passed through the
system at the temperature slightly above the melting point.
From our experience, any volatile impurities are easily removed
during such a preconditioning within few hours. Monitoring
of puriﬁcation is performed by GC analysis of the sample
withdrawn from the cooling trap. The ﬂame-ionization detector
of the GC is not sensitive for water. In order to prove absence
of water traces in the sample, numerous probes were taken
consequently in the course of the sample ﬂushing. After the
amount of compound collected in the cold trap (determined by
GC analysis with an internal standard) within a speciﬁc length
of time became constant, the sample was considered to be ready
for vapor pressure measurements.
2.3. Vapor Pressure and Vaporization Enthalpies.
2.31. Vapor Pressure and Vaporization Enthalpies by
Transpiration. Absolute vapor pressures and vaporization
enthalpy of imidazo[1,2-a]pyrazine over the liquid sample
were determined by the transpiration method as previously
described.15,16 About 0.5 g of the sample was mixed with small
glass beads and placed in a thermostated U-shaped saturator. A
well-deﬁned nitrogen stream was passed through the saturator at
a constant temperature (± 0.1 K), and the transported material
was collected in a cold trap. The amount of condensed sample
of imidazo[1,2-a]pyrazine was determined by GC analysis using
an external standard n-C13H28. The absolute vapor pressure pi at
each temperature Ti was calculated from the amount of the
product collected within a deﬁnite period. Assuming validity of
the Dalton’s law applied to the nitrogen stream saturated with
the substance i, values of pi were calculated with the following
equations:
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where R = 8.314462 J·K−1·mol−1, mi is the mass of the
transported compound, Mi is the molar mass of the compound,
and Vi is its volume contribution to the gaseous phase. VN2 is the
volume of the carrier gas and Ta is the temperature of the soap
bubble meter used for measurement of the gas ﬂow. The volume
of the carrier gas VN2 was determined from the ﬂow rate and the
time measurement. Accuracy of vapor pressures measured by
transpiration method governed mostly by the reproducibility of
the GC analysis as well as by the volume VN2 determination.
16
The standard uncertainties (u) of the measured vapor pressures
have been calculated tobe u(p/Pa) = 0.025 + 0.025(p/Pa) for
p > 5 to 1000 Pa. Vapor pressures of naphthalene, series of
n-alkanols, series of aliphatic esters, where reliable data at p =
(0.1 to 1000) Pa from diﬀerent methods were available. Vapor
pressures of naphthalene, series of n-alkanols, series of aliphatic
esters derived from the transpiration method in the range from
0.1 to 1000 Pa were comparable with available high-precision
data within (1 to 3) %.15,16
Temperature dependence of vapor pressures pi measured for
imidazo[1,2-a]pyrazine was ﬁt with the following equation:15
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where a and b are adjustable parameters and ΔlgCp,m0 is the
diﬀerence of the molar heat capacities of the gaseous and the
liquid phase, respectively. T0, appearing in eq 2, is an arbitrarily
chosen reference temperature, where T0 = 298.15 K in this case,
and R is the molar gas constant, 8.3145 J·K−1·mol−1.
The vaporization enthalpy at temperature T was derived
from the temperature dependence of vapor pressures using eq 3
Δ = − + Δ ·H T b C T( )lg m0 lg p,m0 (3)
The value of ΔlgCp,m0 = −(72.5 ± 16) J·K−1·mol−1 has been cal-
culated according to the procedure developed by Chickos et al.17
based on the isobaric molar heat capacity Cp,m
0 (l, 298.15 K) =
(194.3) J·K−1·mol−1 calculated by the group contribution
method.18,19
Vaporization entropy at temperature T were also derived
from the temperature dependence of vapor pressures using eq 4
Δ = Δ +S T H T R p p( ) / ln( / )il
g
m
0
l
g
m
0 0
(4)
Table 1. Origin and Analysisa of the Heterocycles
compound supplier
purity, mass
fractionb
C4H4N2 pyridazine Sigma-Aldrich 0.98
C5H6N2 3-methylpyridazine Sigma-Aldrich 0.99
C5H6N2 4-methylpyrimidine Sigma-Aldrich 0.97
C6H5N3 imidazo[1,2-a]pyrazine Sigma-Aldrich 0.97
c
C7H6N2 imidazo[1,2-a]pyridine Sigma-Aldrich 0.99
C7H9N 3,5-lutidine Akcros 0.97
C7H12N2 1,5-diazabicyclo[4.3.0]non-
5-ene
Sigma-Aldrich 0.98
C8H6N2 phthalazine Sigma-Aldrich 0.98
C9H7N quinoline Sigma-Aldrich 0.96
C10H8N2 4-phenylpyrimidine Sigma-Aldrich 0.96
aMass fraction. bChemical purity as supplied. See section 2.3.2 for a
discussion of additional puriﬁcation and the eﬀects of chemical purity
on these experiments. cSample purity of imidazo[1,2-a]pyrazine is
discussed in sections 2.1.1, 2.1.2, and 2.2.
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Experimental absolute vapor pressures measured by the trans-
piration method, coeﬃcients a and b of eq 2, as well as values of
ΔlgHm (T) and ΔlgSm0 (T) are provided below. The procedure
for calculation of the combined uncertainties of the vaporiza-
tion enthalpy was described elsewhere.16 It includes uncertain-
ties from the transpiration experimental conditions, uncertain-
ties in vapor pressure, and uncertainties in the temperature
adjustment to T = 298.15 K.
2.32. Vapor Pressure and Vaporization Enthalpies by
Correlation Gas Chromatography. Chemical purity is not of
major concern in correlation gas chromatography experiments
since the chromatography generally separates the various
components. The measurements themselves are performed with
mixtures and provided any impurities are present in minimal
amount, they have little or no eﬀect on retention times as
determined experimentally. Additionally, we have found that even if
two materials have identical retention times, this does not seem to
aﬀect the thermodynamic properties evaluated.20 The experiments
in St. Louis were performed on an HP 5890 gas chromatograph
running HP Chemstation. The column used for all but one analysis
was a 15 m Supelco SPB-5 capillary column, (0.32 mm i.d., 1 μm
ﬁlm thickness) at a split ratio of approximately 100/1. Chromato-
graphs were obtained at T = 5 K increments over a T = 30 K
range. Run 1 was run on an 30 m SPB5 column. Temperature was
controlled by the instrument and monitored by a Fluke digital
thermometer. The solvent used was methanol which also served
the non-retained reference at the temperature of these experiments.
Helium was used as the carrier gas. The standards and target were
injected simultaneously. Retention times are provided in the
Supporting Information (Tables S1A−S5A).
The adjusted retention time, calculated as the diﬀerence
between an analyte’s retention time and that of the unretained
reference, measures the retention time on the column and is
inversely proportional to its vapor pressure oﬀ the column.21
A plot of ln(t0/ta) versus 1/T, where ta represents the adjusted
retention time and t0 is the reference time 60 s, results in a
straight line with a slope equal to −ΔtrnHm(Tm)/R. The term
ΔtrnHm(Tm) refers to the molar enthalpy of transfer from the
stationary phase of the column to the gas phase at the mean
temperature of measurement, Tm, and R is the gas constant.
The enthalpy of transfer is related to the vaporization enthalpy
by eq 5, where ΔintrHm(Tm) represents the enthalpy of interac-
tion of the analyte with the column.21 Provided the standards are
appropriately chosen, a second plot of ΔlgHm(298.15 K) of the
standards against their corresponding ΔtrnHm(Tm) values is also
linear. The equation of this line together with the value of
ΔtrnHm(Tm) of the target provides the ΔlgHm(298.15 K) value
of the target. Heat capacity adjustments of ΔlgHm(Tm) to T =
298.15 K are approximated by the ΔlgHm(298.15 K) values of
the standards
Δ = Δ + ΔH T H T H T( ) ( ) ( )trn m m lg m m intr m m (5)
2.4. Fusion Enthalpy. The fusion enthalpy of imidazo[1,2-
a]pyrazine was measured on a PerkinElmer DSC-7 using the
software provided by the manufacturer (Pyris Series Thermal
Analysis) under a ﬂow of nitrogen at a scan rate of 5 K min−1.
The instrument was calibrated using indium as a standard,
w = 0.99999 (Δcrl H = 28.6 J·g−1; Tfus/K = 429.8), which was
provided by the instrument’s manufacturer. The calibration was
checked using Gold label scintillation grade naphthalene,
w > 0.99 (Tfus/K = 353.7; Δcrl Hm(Tfus) = 19.07 kJ·mol−1;
literature22 = 353.4 K; 19.06 kJ·mol−1). Details are discussed
below.
2.5. X-ray Diﬀraction. The diﬀraction data sets were col-
lected on a Bruker Kappa Apex II Charge Coupled Device
(CCD) Detector system single crystal X-ray diﬀractometer
equipped with an Oxford Cryostream LT device. The SHELXTL-
PLUS software package was used to solve the structure.
Additional details are discussed below and provided in the
Supporting Information
2.6. Infrared Spectroscopy. Infrared spectra of the title
compound were run on an Thermo Nicolet 360 FT IR instru-
ment equipped with an ATR accessory. Spectra of both the
recrystallized and sublimed samples were run. The commercial
sample contain a broad O−H peak at approximately 3200 cm−1,
which was absent in the sublimed material. Otherwise the two
spectra were very similar.
2.7. Temperature Adjustments. All vaporization en-
thalpies used in this work are available at T = 298.15 K having
been adjusted for temperature previously by either the authors
or others.1,2,23−27 The fusion enthalpy of imidazo[1,2-a]-
pyrazine described below was adjusted to T = 298.15 K using
eq 6.19 The heat capacity of both the solid and liquid phases
((Cp(cr) and Cp(l), respectively) of the anhydrous form was
calculated using group addititvity.18 The commercial sample
and the sample obtained by recrystallization was a hydrate and
contained a molecule of water as described below. The heat
capacity of this material was estimated as the sum of the heat
capacity of imidazo[1,2a]pyrazine +1 mol of H2O; (Cp(l)H2O =
75.3 J·mol−1·K−1; Cp(cr)H2O = 34.4 J·mol
−1·K−1). A one-to-one
stoichiometry is suggested by the crystal structure
Δ
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2.8. Uncertainties. The slopes and intercepts reported
below were calculated by linear regression. Uncertainties
associated with results derived by combination of two or more
experimental values were derived as (u1
2 + u2
2 + ...)0.5. All
uncertainties refer to one standard deviation. One standard
deviation associated with adjustment of the fusion enthalpy to
T = 298.15 K is estimated as 30 % of the total temperature
adjustment. The crystallographic reﬁnement program uses
“standard uncertainties”, representing 68 % probability.
2.9. Standards. Two sets of standards were used for the cor-
relation gas chromatography experiments. These are segregated
in Table 2 according to their dipole moments. The ﬁrst group
represents compounds characterized by dipole moments less
than 3.0,1,25−27 whereas the dipole moments in the second group
exceed 3.0 D.1,2,23,24 Two sets of experiments were conducted,
duplicate runs with both sets of standards.
3. RESULTS
3.1. Vaporization Enthalpies. Runs 1 and 2 of Table 3
represent correlations with heterocyclic members associated
with dipole moments < 3.0 D and runs 3−5 of Table 4 cor-
respond to correlations with substances exhibiting values > 3.0 D.
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The equations listed below each respective table deﬁne the
properties of the correlations and the associated correlation
coeﬃcients provide a measure of the linearity of the correlations.
Results of all ﬁve correlations are summarized in Table 5. Two
sets of averages are listed in Table 5, (62.0 ± 2.6) kJ·mol−1
obtained using standards with dipole moments < 3.0 D and
(67.9 ± 1.4) kJ·mol−1 using standards with dipole moments >
3.0 D. The values in column 5 for runs 3−5 were generated
using the most recent value for pyridazine.2 4-Methylpyridazine
was also treated as an unknown. Both sets of vaporization
enthalpy results for 4-methylpyridazine remain within experi-
mental error each other.
In addition to the vaporization enthalpies measured by
correlation, the vaporization enthalpy of imidazo[1,2-a]pyrazine
was also measured by transpiration. These measurements are
summarized in Table 6. A vaporization enthalpy of (70.7 ± 1.0)
kJ·mol−1 measured by transpiration, eq 7, compares quite favorably
with (67.9 ± 1.4) kJ·mol−1 obtained by correlation and suggests
that the value of (62.0 ± 2.6) kJ·mol−1 is incorrect.
Δ = ± ⋅
⋅ = −
− ⋅
−H
R p p T
T
Imidazo[1,2-a]pyrazine; (298.15 K) (70.7 1.0) kJ mol
ln( / ) 307.65 92341.6/( /K)
72.5 ln [( /K)/298.15]
o
1
g
m
1
(7)
These results support the notion that the imidazo[1,2-a]pyrazine
core is a member of the more polar group and presumable is
characterized by a dipole moment > 3.0 D. Using the average value
of both results, (69.3 ± 1.2) kJ·mol−1, comparison with the average
of runs 1 and 2 results in a diﬀerence of (7.3 ± 1.2) kJ·mol−1, in
very good agreement with diﬀerences of (6.9 ± 0.3) kJ·mol−1
observed previously for the other compounds in this class.
3.2. Fusion Enthalpy. The DSC curve for the commercial
sample of imidazo[1,2-a]pyrazine recrystallized from ethyl
acetate is shown as the upper curve in Figure 4. Following the
structural analysis described below, which indicated the
presence of a hydrate, the sample was sublimed and this
resulted in a sample that exhibited the lower curve in Figure 4.
The small peak observed at T = (334.1 ± 0.1) K compares to a
fusion temperature of Tfus = (336.3 ± 0.1) K for the hydrate
and is most likely due to the presence of a small amount of
hydrate. Accordingly, using the fusion data in Table 7A for the
hydrated form, the enthalpy associated with transition at T =
(334.1 ± 0.1) K amounts to a total of 3.7 % hydrate present in
the anhydrous form as evaluated by DSC. Adjusting the fusion
enthalpy of (14.7 ± 1.2) kJ·mol−1 for its presence, results in a
fusion enthalpy of (15.3 ± 1.3) kJ·mol−1 for the anhydrous
form which melts at Tfus = (359.2 ± 0.6) K. This is summarized
in Table 7B. The hydrated form melts at a lower temperature
but exhibits a larger fusion enthalpy, (19.6 ± 0.6) kJ·mol−1. The
fusion enthalpy of the anhydrous form at T = 298.15 K is
estimated as (12.8 ± 1.5) kJ·mol−1. The temperature adjust-
ment is summarized in the last row of Table 7B.
3.3. Sublimation Enthalpy. The sublimation enthalpy of
imidazo[1,2-a]pyrazine can be calculated as the sum of its vapori-
zation and fusion enthalpy, (69.3 ± 1.2) + (12.75 ± 1.5) kJ·mol−1.
A value of at (82.1 ± 1.9) kJ·mol−1 is calculated at T = 298.15 K.
3.4. Crystal Structures. Extensive conjugation, planarity
and polarity are common properties exhibited by two of the
crystalline members that exhibit enhanced vaporization
enthalpies.1 In an eﬀort to determine whether imidazo[1,2-a]-
pyrazine and phthalazine pack in a manner similar to benzo-
[c]cinnnoline14 and 1,2,4-triazolo[1,5-a]pyrimidine,1 the crystal
structures of both were determined. All other current members
of this group are liquids at T = 298.15 K.
Table 2. Vaporization Enthalpies of the Standards
dipole moment < 3.0 D ΔlgHm(298 K) (literature) ref
kJ·mol−1
4-methylpyrimidine 44.2 ± 2.5 25
3,5-lutidine 49.32 ± 0.17 26
quinoline 59.31 ± 0.2 27
1,5-diazabicyclo[4.3.0]non-5-ene 61.88 ± 0.21 1
4-phenylpyrimidine 68.8 ± 2.5 25
dipole moment > 3.0 D ΔlgHm(298 K) (literature) ref
kJ·mol−1
pyridazine 54.6 ± 0.2, 53.5 ± 0.4 2, 24
3-methylpyridazine 56.1 ± 4.4 23
imidazo[1,2-a]pyridine 67.41 ± 0.23 1
phthalazine 72.8 ± 5.6 23
Table 3. Correlation of ΔlgHm(298 K) with ΔHtrn(Tm) for Runs 1 and 2a
slope, T intercept ΔHtrn(424 K) ΔlgHm(298 K) (literature) ΔlgHm(298 K) (calcd)
run 1 K kJ·mol−1 kJ·mol−1 kJ·mol−1
4-methylpyrimidine −3498.1 9.647 29.08 44.2 ± 2.4 44.1 ± 1.1
3,5-lutidine −4033.8 10.162 33.54 49.32 ± 0.17 49.7 ± 1.1
quinoline −4907.8 10.866 40.80 59.31 ± 0.2 58.9 ± 1.2
1,5-diazabicyclo[4.3.0]non-5-ene −5194.0 11.516 43.18 61.88 ± 0.21 61.9 ± 1.3
imidazo[1,2-a]pyrazine −5185.9 11.336 43.11 61.8 ± 1.3
4-phenylpyrimidine −5857.1 12.089 48.69 68.8 ± 2.5 68.9 ± 1.4
slope, T intercept ΔHtrn(425 K) ΔlgHm(298 K) (literature) ΔlgHm(298 K) (calcd)
run 2 K kJ·mol−1 kJ·mol−1 kJ·mol−1
4-methylpyrimidine −3411.8 9.507 28.36 44.2 ± 2.4 44.2 ± 3.4
3,5-lutidine −3990.2 10.129 33.17 49.32 ± 0.17 50.2 ± 3.6
quinoline −4813.4 10.707 40.02 59.31 ± 0.2 58.8 ± 4.0
1,5-diazabicyclo[4.3.0]non-5-ene −4976.1 11.082 41.37 61.88 ± 0.21 60.5 ± 4.0
imidazo[1,2-a]pyrazine −5126.5 11.27 42.62 62.1 ± 4.1
4-phenylpyrimidine −5854.7 12.157 48.67 68.8 ± 2.5 69.7 ± 4.4
Run 1: ΔlgHm(298.15 K)/kJ·mol−1 = (1.27 ± 0.02) ΔHtrn (424 K) + (7.18 ± 0.9); r2 = 0.9991
Run 2: ΔlgHm(298.15 K)/kJ·mol−1 = (1.26 ± 0.07) ΔHtrn (425 K) + (8.54 ± 2.8); r2 = 0.9905
aUncertainties are one standard deviation; p/Pa = 101325.
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3.4.1. Imidazo[1,2-a]pyrazine. The crystal structure of a
sample of imidazo[1,2-a]pyrazine from ethyl acetate−hexane
corresponding to the upper DSC curve in Figure 4 was found
to be disordered. One feature that the structure did reveal was
the presence of a stoichiometric amount of water in the crystal.
The presence of water was also conﬁrmed as noted above
by the infrared spectrum of both the commercial sample as
supplied and the one recrystallized. Both samples contained a
broad O−H stretch at approximately 3300 cm−1. Despite being
disordered, the hydrated structure could be solved and reﬁned
in both the monoclinic (P21/n) and triclinic space group P-1,
shown in Figure 5. In both cases the fused ring system and
the solvent molecules remain disordered. The root mean
square deviation of the overlay of the two disordered molecules
(87:13 %) in the monoclinic and the 2-unique molecules in the
triclinic space groups results in very similar values, which
indicates that the two molecules in the asymmetric unit of the
triclinic space group are the same. Examination of the extended
lattice packing of the hydrated structure shows that the water
molecules are not hydrogen bonded in the lattice but are simply
ﬁlling the crystal voids. Because no improvement in structural
parameters were observed by lowering the symmetry, the
monoclinic space group was used for this report. Additional
details are provided in the Supporting Information Figure S1
and Tables S6−S8.
In an eﬀort to remove the water, a sample recrystallized from
ethyl acetate−hexane was also vacuum sublimed and its crystal
structure determined. The structure of this material corre-
sponding to the lower DSC curve in Figure 4 is illustrated in
Figure 6. Like 1,2,4-triazolo[1,5-a]pyrimidine, the molecule is
planar despite the presence of a tricoordinate nitrogen atom.
The anhydrous form crystallized in the orthorhombic crystal
Table 4. Correlation of ΔlgHm(298 K) with ΔHtrn (Tm) for Runs 3, 4, and 5a
slope, T intercept ΔHtrn(424 K) ΔlgHm(298 K) (literature) ΔlgHm(298 K) (calcd)
run 3 K kJ·mol−1 kJ·mol−1 kJ·mol−1
pyridazine −3707.5 9.382 30.82 54.62 ± 0.22 54.7 ± 1.7
3-methylpyridazine −4051.8 9.794 33.69 57.8 ± 1.8
imidazo[1,2-a]pyridine −5100.2 10.868 42.40 67.41 ± 0.23 67.1 ± 2.0
imidazo[1,2-a]pyrazine −5185.0 10.987 43.11 67.8 ± 2.0
phthalazine −5769.8 11.433 47.97 72.8 ± 5.6 73.0 ± 2.1
slope, T intercept ΔHtrn(414 K) ΔlgHm(298 K) (literature) ΔlgHm(298 K) (calcd)
run 4 K kJ·mol−1 kJ·mol−1 kJ·mol−1
pyridazine −3492.7 9.171 29.04 54.62 ± 0.22 54.6 ± 0.9
3-methylpyridazine −3912.6 9.795 32.53 58.0 ± 1.0
imidazo[1,2-a]pyridine −5088.3 11.235 42.30 67.41 ± 0.23 67.6 ± 1.1
imidazo[1,2-a]pyrazine −5181.6 11.388 43.08 68.4 ± 1.1
phthalazine −5706.1 11.735 47.44 72.8 ± 5.6 72.7 ± 1.2
slope, T intercept ΔHtrn(424 K) ΔlgHm(298 K) (literature) ΔlgHm(298 K) (calcd)
run 5 K kJ·mol−1 kJ·mol−1 kJ·mol−1
pyridazine −3842.6 10.042 31.95 54.62 ± 0.22 54.6 ± 1.0
3-methylpyridazine −4215.2 10.529 35.04 58.1 ± 1.0
imidazo[1,2-a]pyridine −5211.3 11.52 43.32 67.41 ± 0.23 67.6 ± 1.1
imidazo[1,2-a]pyrazine −5216.5 11.471 43.37 67.6 ± 1.1
phthalazine −5748.4 11.843 47.79 72.8 ± 5.6 72.7 ± 1.2
Run 3: ΔlgHm(298.15 K)/kJ·mol−1 = (1.067 ± 0.033)ΔHtrn(424 K) − (21.8 ± 1.4); r2 = 0.9990
Run 4: ΔlgHm(298.15 K)/kJ·mol−1 = (0.983 ± 0.02)ΔHtrn(414 K) − (26.0 ± 0.75); r2 = 0.9996
Run 5: ΔlgHm(298.15 K)/kJ·mol−1 = (1.14 ± 0.02)ΔHtrn(424 K) − (18.1 ± 0.8); r2 = 0.9997
aUncertainties are one standard deviation, p = 101325 Pa.
Table 5. Summary of the Vaporization Enthalpies of Runs 1−5
ΔlgHm
kJ·mol−1
Run 1 Run 2 Averagea Literature
4-methylpyrimidine 44.1 ± 1.1 44.2 ± 3.4 44.2 ± 2.3 44.2 ± 2.4
3,5-lutidine 49.7 ± 1.1 50.2 ± 3.6 50.0 ± 2.4 49.32 ± 0.17
quinoline 58.9 ± 1.2 58.8 ± 4.0 58.9 ± 2.6 59.31 ± 0.2
1,5-diazabicyclo[4.3.0]non-5-ene 61.9 ± 1.3 60.5 ± 4.0 61.2 ± 2.7 61.88 ± 0.21
imidazo[1,2-a]pyrazine 61.8 ± 1.3 62.1 ± 4.1 62.0 ± 2.6
4-phenylpyrimidine 68.9 ± 1.4 69.7 ± 4.4 69.4 ± 2.9 68.8 ± 2.5
Run 3 Run 4 Run 5 Average literature
pyridazine 54.7 ± 1.7 54.6 ± 0.9 54.6 ± 1.0 54.6 ± 1.2 54.62 ± 0.22
3-methylpyridazine 57.8 ± 1.8 58.0 ± 1.0 58.1 ± 1.0 58.0 ± 1.3 56.1 ± 4.4
imidazo[1,2-a]pyridine 67.1 ± 2.0 67.6 ± 1.1 67.6 ± 1.1 67.4 ± 1.4 67.41 ± 0.23
imidazo[1,2-a]pyrazine 67.8 ± 2.0 68.4 ± 1.1 67.6 ± 1.1 67.9 ± 1.4
phthalazine 73.0 ± 2.1 72.7 ± 1.2 72.7 ± 1.2 72.8 ± 1.5 72.8 ± 5.6
aUncertainties are one standard deviation averaged, p = 101325 Pa.
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system, space group Pbca. An examination of the packing,
Figure 6, indicates that at least in the solid state of this
crystalline form, π−π stacking is not important because no two
molecules pack in parallel planes. Additional details of this
structure are given in the Supporting Information Figure S2
and Tables S9−S13.
A third sample that was sublimed and then recrystallized
from heptane also contained water but was no longer
disordered. In this structure, Figure 7, the water molecules
are actively involved in the crystal lattice. Although the unit cell
shows no evidence of π−π stacking, extending the packing
reveals a coplanar neighboring molecule 3.402 Å apart. In this
case, the overlap occurs primarily between the six membered
ring of one molecule and a portion of the ﬁve-membered ring
of a second molecule. The X-ray crystal structure of this form
was of relatively poor quality. Additional details for this hydrate
are also provided in the Supporting Information Figure S3 and
Tables S14−S20.
3.4.2. Phthalazine. Phthalazine is another crystalline hetero-
cycles with a large dipole moment and characterized by an
enhanced vaporization enthalpy. This material crystallized in
the orthorhombic Pbca space group. The unit cell is shown in
Figure 8. The solid state structure of phthalazine does show
π−π stacking similar to benzo[c]cinnoline. The structure can be
considered an assembly of isolated coplanar pairs of molecules
Figure 4. DSC of imidazo[1,2-a]pyrazine hydrate (top) and the
anhydrous form containing approximately 3.7 % of the hydrate.
Table 6. Vaporization Enthalpy of Imidazo[1,2-a]pyrazine by Transpiration
Ta mb V(N2)
c
ﬂow pd u(p)e Δl
gHm
0 Δl
gSm
0
K mg dm3 dm3·h−1 Pa % kJ·mol−1 J·K−1·mol−1
369.6 9.72 1.217 1.04 164.1 4.1 65.56 124.1
372.7 2.58 0.276 5.52 192.0 4.8 65.33 123.3
373.8 9.49 0.956 1.04 203.8 5.1 65.25 123.1
377.8 3.01 0.243 1.04 253.6 6.4 64.96 122.3
379.0 8.96 0.695 1.04 264.3 6.6 64.88 121.8
383.0 11.53 0.695 1.04 340.0 8.5 64.59 121.4
385.2 9.49 0.522 1.04 373.0 9.4 64.43 120.8
388.2 9.29 0.435 1.04 438.1 11.0 64.21 120.3
390.2 9.66 0.400 1.04 495.2 12.4 64.06 120.1
393.4 12.37 0.435 1.04 583.2 14.6 63.83 119.5
aSaturation temperature (u(T) = 0.1 K). bMass of transferred sample condensed at T = 243 K. cVolume of nitrogen (u(V) = 0.005 dm3)
used to transfer m (u(m) = 0.0001 g) of the sample. dVapor pressure at temperature T, calculated from the m and the residual vapor pres-
sure at T = 243 K. eUncertainties of experimental vapor pressures were calculated according to the following equation: u(p/Pa) = 0.025 + 0.025(p/
Pa)p0 = 1 Pa.
Table 7A. Fusion Enthalpy of Imidazo[1,2-a]pyrazine·H2O, Δcrl Hm(Tfus), Liquid and Crystalline Heat Capacity, Cp(l)/Cp(cr),
and the Temperature Adjustment, Δcrl Cp·ΔTa
sample onset Δcrl Hm(Tfus) Δcrl Hm(Tfus) Cp(l)/Cp(cr)b Δcrl Cp·ΔT Δcrl Hm(298 K)
mg K J·g−1 kJ·mol−1 J·mol−1·K−1 kJ·mol−1 kJ·mol−1
6.27 336.49 165.9 19.766
5.46 336.23 164.5 19.592
6.12 336.25 162.4 19.348
average 336.33 ± 0.14 164.3 ± 1.8 19.6 ± 0.21 269.6/161.2 −2.13 ± 0.6 17.4 ± 0.6
aUncertainties are one standard deviation, p = 101325 Pa. bEstimated as the sum of the heat capacity of the anhydrous form and the heat capacity of
1 mol of liquid/solid water; 75.3/36.6 J·mol−1·K−1.
Table 7B. Fusion Enthalpy of Anhydrous Imidazo[1,2-a]pyrazine
Δcrl Hm(Tfus)
sample onset Δcrl Hm(T) onset measured adjusteda Cp(l)/Cp(cr) Δcrl Cp·ΔT Δcrl Hm(298 K)
mg K J/g−1 K kJ·mol−1 J·mol−1·K−1 kJ·mol−1 kJ·mol−1
13.99 334.19 5.29 360.0 14.4
9.2 333.98 6.9 358.9 16.0
12.4 334.04 6.2 358.8 13.7
average 334.1 ± 0.1 6.12 ± 0.8 359.2 ± 0.6 14.7 ± 1.2 15.3 ± 1.3 194.3/121.8 −2.6 ± 0.8 12.7 ± 1.5
aFraction of hydrate, (6.12 ± 0.8)/(164.3 ± 1.8) = 0.037 ± 0.005; fraction of anhydrous, 0.963 ± 0.005
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3.418 Å apart with centroid to centroid distance of the two
benzene rings of the heterocycle, 3.663 Å apart. Additional
details of the structure are also provided in the Supporting
Information Figure S4 and Tables S21−S26.
4. CONCLUSION
Although many of the materials with large dipole moments
show evidence of π−π stacking in the solid state, this criterion
does not seem to be satisﬁed by the packing observed in
imidazo[1,2-a]pyrazine. The situation in the liquid phase may
diﬀer. However, π−π stacking in the solid state does not appear
to be a necessary criterion for the enhanced polarity exhibited
by this group of molecules. Even in cases where π−π stacking
is observed, there appears to be no consistency in how the
molecules stack. In phthalazine, stacking is such that only
the benzenoid portions of the two molecules are overlapping,
whereas in the hydrate of imidazo[1,2-a]pyrazine, it is the ﬁve-
membered ring of one molecule π stacked on the benzenoid
portion of a second molecule. In benzo[c]cinnoline, π−π
stacking occurs mainly between the biphenyl portions of the
two molecules. The nitrogen atoms of the two molecules are
pointing in opposite directions. As a result, it is diﬃcult to
rationalize a constant enthalpy of interaction given such diﬀerent
structural arrangements.28 Nevertheless, on the basis of the
vaporization enthalpy results, imidazo[1,2-a]pyrazine must also
Figure 5. Disordered crystal structure of imidazo[1,2-a]pyrazine hydrate.
Figure 6. Packing in the unit cell of anhydrous imidazo[1,2-a]pyrazine.
Figure 7. Packing of imidazo[1,2-a]pyrazine hydrate.
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be classiﬁed as a member of the group of polar molecules. What
continues to be poorly understood is the reason why substances
that vary signiﬁcantly in polarity, as characterized by dipole
moments from 0 D to 3.0 D, correlate successfully with each
other, whereas those in excess of 3.0 D likewise correlate with
each other, but diﬀer from the former by a relatively constant
diﬀerence of (6.9 ± 0.3) kJ·mol−1.
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Ramos-Lima, F.; Cendoń, E.; Cebriań, D.; Aguirre, E.; Gomez-Casero,
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